VASOPRESSIN STIMULATES THE PRODUCTION OF EXTRACELLULAR MATRIX BY CULTURED RAT MESANGIAL CELLS

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2008-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1440-1681.2007.04852.xPMID 18177476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy.

  2007cited by this paper
• Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance

  2007cited by this paper
• Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist.

  2005cited by this paper
• Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET(A) receptor antagonist.

  2003cited by this paper
• Physiology and pathology of endothelin-1 in renal mesangium.

  2003cited by this paper
• Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells.

  1997cited by this paper
• An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis.

  1996cited by this paper
• Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.

  1996cited by this paper
• Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth.

  1996cited by this paper
• Vasoactive hormones and renal sclerosis.

  1996cited by this paper
• Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

  1996cited by this paper
• ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis.

  1995cited by this paper
• Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

  1994cited by this paper
• Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney.

  1994cited by this paper
• Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

  1994cited by this paper
• Divergent effects of arginine vasopressin and angiotensin II on proliferation and expression of the immediate early genes c-fos, c-jun and Egr-1 in cultured rat glomerular mesangial cells

  1993cited by this paper
• A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression.

  1993cited by this paper
• Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells.

  1992cited by this paper
• Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

  1992cited by this paper
• Transforming growth factor-beta in disease: the dark side of tissue repair.

  1992cited by this paper
• Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells.

  1992cited by this paper
• Mesangial cell turnover: effect of heparin and peptide growth factors.

  1991influential reference
• Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions.

  1991cited by this paper
• Transforming growth factor-beta 1 enhances the proliferative effects of epidermal growth factor on vascular smooth muscle from the spontaneously hypertensive rat.

  1991cited by this paper
• The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells.

  1990cited by this paper
• Acetaldehyde selectively stimulates collagen production in cultured rat liver fat‐storing cells but not in hepatocytes

  1990cited by this paper
• Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?

  1990cited by this paper
• The contribution of glomerular mesangial cells to progressive glomerulosclerosis.

  1989cited by this paper
• Physiology of the mesangial cell.

  1989cited by this paper
• Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries.

  1989cited by this paper
• Extracellular matrix and glomerular disease.

  1989influential reference
• Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture.

  1988cited by this paper
• Thrombospondin secretion by cultured human glomerular mesangial cells.

  1987cited by this paper
• The glomerular mesangial cell: an expanding role for a specialized pericyte

  1987cited by this paper
• Immunohistochemical distribution of collagens types IV, V, and VI and of pro-collagens types I and III in human alveolar bone and dentine.

  1986cited by this paper
• Recent advances in the biochemistry of glomerular basement membrane.

  1986cited by this paper
• Mesangium and glomerular disease.

  1985influential reference
• Structural-functional relationships in diabetic nephropathy.

  1984cited by this paper
• Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat.

  1981cited by this paper
• Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin.

  1980cited by this paper
• Tissue culture of normal rat glomeruli. Basement membrane biosynthesis by homogeneous epithelial and mesangial cell lines.

  1980cited by this paper
• Enzyme-linked immunoassay (ELISA) for connective tissue components.

  1980cited by this paper
• Synthesis of collagen and fibronectin by glomerular cells in culture.

  1980cited by this paper

• Liver cirrhosis reversion is improved in hamsters with a neurointermediate pituitary lobectomy.

  2017cites this paper
• Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.

  2017cites this paper
• New concepts in endothelin control of sodium balance

  2012cites this paper
• Endothelin and endothelin receptors in the renal and cardiovascular systems.

  2012cites this paper
• Effects of High Glucose on AVP-Induced Hyperplasia, Hypertrophy, and Type IV Collagen Synthesis in Cultured Rat Mesangial Cells

  2012cites this paper
• Mecanismes d’acció de l’aldosterona i de la vasopressina en la regulació de les funcions del còlon

  2012cites this paper
• Vasopressin V1a and V1b receptors: from molecules to physiological systems.

  2012cites this paper
• Effect of Simvastatin on Expression of Transforming Growth Factor-β and Collagen Type IV in Rat Mesangial Cells

  2011cites this paper
• Renal function and blood pressure: molecular insights into the biology of endothelin-1.

  2011cites this paper
• Vasopressin regulates rat mesangial cell growth by inducing autocrine secretion of vascular endothelial growth factor

  2011cites this paper
• Vasopressin beyond water: implications for renal diseases

  2010cites this paper
• Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?

  2009cites this paper
• Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence

  2009cites this paper
• Experimental models for nephropathy

  2008cites this paper
• Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy?

  2008cites this paper